Global Syphilis Sequencing

CompletedOBSERVATIONAL
Enrollment

726

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

February 28, 2022

Conditions
Syphilis
Interventions
DIAGNOSTIC_TEST

Whole Genome Sequencing

Residual DNA from clinical samples will be utilised for whole genome sequencing of Treponema pallidum the causative agent of syphilis

Trial Locations (5)

Unknown

University Hospitals Birmingham, Birmingham

Brighton and Sussex NHS Trust, Brighton

Leeds University Teaching Hospital, Leeds

Mortimer Market Centre, London

Penine Acute Hospitals Trust, Manchester

All Listed Sponsors
collaborator

Wellcome Sanger Institute

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03709862 - Global Syphilis Sequencing | Biotech Hunter | Biotech Hunter